Evaluation of Pharmacist Impact on Blood Pressure Management in an Ambulatory Care Cardiology Clinic

Document Type

Conference Proceeding

Publication Date

3-6-2026

Publication Title

Am J Health Syst Pharm

Keywords

adult, ambulatory care, blood pressure, body weight change, chi square distribution, clinical article, conference abstract, controlled study, drug therapy, female, hospice care, hospital admission, human, hypertension, hypotension, male, medical record review, outpatient department, patient compliance, people by smoking status, pharmacist, retrospective study

Abstract

Purpose: Hypertension (HTN) impacts approximately half of all United States adults, with only a quarter considered controlled. Previous studies suggest the addition of an ambulatory care pharmacist to physician care over physician care alone positively impacts HTN outcomes. The management of HTN directly provided by a pharmacist has resulted in achieving blood pressure goals in less time and at a lower overall cost. As a result of the recent incorporation of a pharmacist in the Henry Ford Genesys Heart Center outpatient clinic, this study aims to assess the clinical benefit and financial impact of this program. Methods: This single-center, retrospective, chart review study will be conducted at Henry Ford Genesys Heart Center and Henry Ford Genesys Hospital. The inclusion criteria of this study are as follows: ages 18 years and older, HTN diagnosis, and patients with at least 2 or more clinic visits. Exclusion criteria include patients who are pregnant or in hospice care. The primary outcome that will be evaluated in this study is time to goal blood pressure (BP) from baseline, measured in weeks. Secondary outcomes evaluated in this study include overall change in BP, change in number of total BP-lowering medications, number of visits to reach goal BP, patient adherence (proportion of days covered) to BP-lowering medications, change in weight, change in smoking status, total cost to reach goal BP, and hospital admission with primary reason of hypertension or hypotension. The patient population will be randomized 1:1 with an alpha of 0.05 and power of 80%, and a detectable difference in time to goal of 3 weeks. To achieve these parameters, a sample size of 44 participants is required. A Mann-Whitney U test will be utilized to assess continuous data, including time to goal BP, while a chi-square test will be utilized to assess all secondary nominal outcomes.

Volume

83

Issue

Supplement_2

First Page

S799

Find It @ Sladen

Share

COinS